Open-Label Early-Access Programs (EAPs) for Ibrutinib in Patients with Relapsed/ Refractory Chronic Lymphocytic Leukemia (CLL) or Mantle-Cell Lymphoma (MCL)

Autor: Chiattone, Carlos Sérgio, Hamerschlak, Nelson, Fogliatto, Laura, Scheinberg, Phillip, Bigni, Ricardo, Rodrigues, Celso *, Garicochea, Bernardo *, Pimenta, Alex *, Boechat, Tiago Oliveira *, Musacchio, Juliane *, Bortolini, Jaisson *, Goncalves, Iara Zapparoli *, Vieira, Garles Miller Matias *, Buccheri, Valeria *, Santos, Telma *, Grings, Mariana *, Parisi, Lori *, Barreyro, Paula *
Zdroj: In Blood 29 November 2018 132 Supplement 1:5554-5554
Databáze: ScienceDirect